These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25812380)

  • 21. Diabetic autonomic neuropathy.
    Ahmed AM; Hussein A; Ahmed NH
    Saudi Med J; 2000 Nov; 21(11):1034-7. PubMed ID: 11360064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short term fluctuations in blood glucose concentrations do not alter pain perception in diabetic-patients with and without painful peripheral neuropathy.
    Chan AW; MacFarlane IA; Bowsher D
    Diabetes Res; 1990 May; 14(1):15-9. PubMed ID: 2134661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathogenesis and treatment of diabetic neuropathy].
    Grzelec H
    Neurol Neurochir Pol; 1991; 25(4):477-84. PubMed ID: 1666426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diabetic somatic polyneuropathy. Pathogenesis, clinical manifestations and therapeutic concepts].
    Hilz MJ; Marthol H; Neundörfer B
    Fortschr Neurol Psychiatr; 2000 Jun; 68(6):278-88. PubMed ID: 10923253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diabetic neuropathy].
    Chudzik W; Kaczorowska B; Przybyła M; Chudzik B; Gałka M
    Pol Merkur Lekarski; 2007 Jan; 22(127):66-9. PubMed ID: 17477095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic neuropathy.
    Brown MJ; Asbury AK
    Ann Neurol; 1984 Jan; 15(1):2-12. PubMed ID: 6370098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of diabetic neuropathy].
    Hirose T
    Masui; 2010 Nov; 59(11):1378-84. PubMed ID: 21077305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiovascular autonomic neuropathy and nephropathy in patients with type-1 diabetes mellitus].
    Galicka-Latała D; Fedak D; Kuźniewski M; Kawalec E; Solnica B
    Przegl Lek; 2004; 61(3):155-8. PubMed ID: 15518324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Two cases of medicinal treatment of diabetic post treatment painful neuropathy].
    Yanaki M; Iwade M; Yamagata K; Hamada K; Ozaki K; Higuchi H; Ozaki M
    Masui; 2013 Dec; 62(12):1400-5. PubMed ID: 24498768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy.
    Negrişanu G; Roşu M; Bolte B; Lefter D; Dabelea D
    Rom J Intern Med; 1999; 37(3):297-306. PubMed ID: 15532308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.
    Chilelli NC; Burlina S; Lapolla A
    Nutr Metab Cardiovasc Dis; 2013 Oct; 23(10):913-9. PubMed ID: 23786818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical evaluation and treatment of diabetic peripheral neuropathy.
    Petit WA; Upender RP
    Clin Podiatr Med Surg; 2003 Oct; 20(4):671-88. PubMed ID: 14636032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic neuropathy.
    Vinik AI; Nevoret ML; Casellini C; Parson H
    Endocrinol Metab Clin North Am; 2013 Dec; 42(4):747-87. PubMed ID: 24286949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic neuropathy.
    Smith AG; Singleton JR
    Continuum (Minneap Minn); 2012 Feb; 18(1):60-84. PubMed ID: 22810070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of trolox on nerve dysfunction, thermal hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sharma SS; Sayyed SG
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1022-8. PubMed ID: 17042909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic neuropathy: therapies for peripheral and autonomic symptoms.
    Emanuele NV; Emanuele MA
    Geriatrics; 1997 Apr; 52(4):40-2, 45-9. PubMed ID: 9119237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tolrestat in the therapy of diabetic peripheral neuropathy: is this drug really useful?].
    Daniele E; Coco MP
    Clin Ter; 1995 Dec; 146(12):793-99. PubMed ID: 8681499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy.
    Sayyed SG; Kumar A; Sharma SS
    Life Sci; 2006 Jul; 79(8):777-83. PubMed ID: 16581090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy.
    Kamboj SS; Vasishta RK; Sandhir R
    J Neurochem; 2010 Jan; 112(1):77-91. PubMed ID: 19840221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism.
    Greene DA; Lattimer-Greene S; Sima AA
    Crit Rev Neurobiol; 1989; 5(2):143-219. PubMed ID: 2561904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.